🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Tesla, Vir Biotechnology, Illumina Rise Premarket; Rivian Falls

Published 01/11/2022, 07:51 AM
© Reuters
INTC
-
IBM
-
MU
-
GE
-
CVS
-
ILMN
-
TSLA
-
TWTR
-
VIR
-
RIVN
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Tuesday, January 11th. Please refresh for updates.

  • Tesla (NASDAQ:TSLA) stock rose 0.9% after the U.S. electric vehicle maker sold 70,847 China-made vehicles in December, the highest monthly rate since it started manufacturing in Shanghai in 2019.

  • Twitter (NYSE:TWTR) stock rose 0.6% after the social media giant bought a minority stake in digital advertising startup Aleph Group.

  • Rivian (NASDAQ:RIVN) stock fell 4.1% following reports that head of operations Rod Copes left the electric vehicle maker at the end of last month.

  • General Electric (NYSE:GE) stock rose 1% after Bernstein initiated coverage of the industrial conglomerate with a “buy” rating, saying the stock can rally 20% ahead of its three-way split.

  • CVS Health (NYSE:CVS) stock rose 1.3% after the pharmacy chain raised its full-year earnings outlook, benefiting from the need for customers to buy Covid tests and remedies.

  • Intel (NASDAQ:INTC) stock rose 1.1% after the chipmaker named Micron (NASDAQ:MU) finance head David Zinsner as CFO and executive vice president from Jan. 17. Micron stock fell 0.5%.

  • Vir Biotechnology (NASDAQ:VIR) stock rose 8.9% after the United States agreed to buy 600,000 more doses of the antibody-based Covid-19 treatment the U.S. drugmaker manufacturers with British partner GSK. 

  • Illumina (NASDAQ:ILMN) stock rose 4.5% after impressing with its 2022 revenue outlook, noting strong demand for its gene sequencing treatments.

  • IBM (NYSE:IBM) stock fell 2.6% after UBS downgraded its stance on the tech giant to “sell” from “neutral”, citing an elevated valuation.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.